Everything You Need to Know About Compounded GLP-1s in 2026 | Karla Palmer

Compounded GLP-1 medications have become one of the most talked-about topics in healthcare, but there’s also a tremendous amount of confusion surrounding their legality, safety, and role in patient care. In this episode of Everything GLP-1, Dr. Tom Lavin sits down with Karla Palmer, one of the nation’s leading FDA and DEA regulatory attorneys, to break through the misinformation and explain what patients need to know. With more than three decades of experience advising pharmacies, manufacturers, and healthcare providers, Karla explains how compounded medications have been a vital part of American healthcare for decades, why 503A compounding pharmacies exist, and what changed after the GLP-1 shortages officially ended. Together, they discuss the important differences between legally compounded medications and unregulated research peptides, how patients can identify safe sources of treatment, and why physician oversight remains essential. Whether you’re currently taking a GLP-1, considering treatment, or simply trying to understand the rapidly changing landscape, this conversation offers clear, practical insight into the future of compounded GLP-1s, peptide therapies, and FDA regulation. It’s an essential episode for anyone who wants to make informed decisions about their health with facts instead of headlines.https://www.yourera.com/ Hosted on Acast. See acast.com/privacy for more information.